PubGene collaborates with the Section for Research and Innovation at Haukeland University Hospital. Haukeland facilitates increased quality and quantity of clinical research, so that the health services can provide a better offer to the population in a cost-effective way. Haukeland provides feedback on the Coremine Vitae (CMV) product, and clinically validates and document its added value to clinicians and patients. The aim is also to facilitate CMV patient trials.
